Four Peer-Reviewed Clinical Study Publications Build a Substantial Evidence Base for Oxaloacetate CFS in ME/CFS and Long COVID

Research published in the Journal of Translational Medicine, Frontiers in Neurology and Frontiers in Neuroscience journals finds oxaloacetate improves ME/CFS and Long COVID symptoms including physical fatigue, mental fatigue, cognition, symptom burden and upright activity. SAN DIEGO, Calif. — August 2026 — Terra Biological today highlighted the substantial and growing body of clinical evidence…